Geode Capital Management’s Harvard Bioscience HBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$195K Sell
440,022
-483,039
-52% -$214K ﹤0.01% 3884
2025
Q1
$523K Buy
923,061
+3,992
+0.4% +$2.26K ﹤0.01% 3526
2024
Q4
$1.94M Buy
919,069
+6,470
+0.7% +$13.7K ﹤0.01% 3140
2024
Q3
$2.46M Buy
912,599
+19,972
+2% +$53.7K ﹤0.01% 3061
2024
Q2
$2.54M Buy
892,627
+36,403
+4% +$104K ﹤0.01% 3049
2024
Q1
$3.63M Buy
856,224
+51,588
+6% +$219K ﹤0.01% 2869
2023
Q4
$4.31M Buy
804,636
+26,580
+3% +$142K ﹤0.01% 2786
2023
Q3
$3.35M Buy
778,056
+53,327
+7% +$229K ﹤0.01% 2846
2023
Q2
$3.98M Buy
724,729
+385,706
+114% +$2.12M ﹤0.01% 2815
2023
Q1
$1.42M Buy
339,023
+2
+0% +$8 ﹤0.01% 3179
2022
Q4
$939K Buy
339,021
+2,648
+0.8% +$7.33K ﹤0.01% 3373
2022
Q3
$861K Buy
336,373
+684
+0.2% +$1.75K ﹤0.01% 3471
2022
Q2
$1.21M Sell
335,689
-313,636
-48% -$1.13M ﹤0.01% 3339
2022
Q1
$4.03M Buy
649,325
+6,425
+1% +$39.9K ﹤0.01% 2924
2021
Q4
$4.53M Buy
642,900
+11,012
+2% +$77.6K ﹤0.01% 2946
2021
Q3
$4.41M Buy
631,888
+17,925
+3% +$125K ﹤0.01% 2977
2021
Q2
$5.11M Buy
613,963
+12,924
+2% +$108K ﹤0.01% 2891
2021
Q1
$3.28M Buy
601,039
+54,325
+10% +$297K ﹤0.01% 2997
2020
Q4
$2.35M Buy
546,714
+19,762
+4% +$84.8K ﹤0.01% 2997
2020
Q3
$1.59M Buy
526,952
+6,302
+1% +$19K ﹤0.01% 3001
2020
Q2
$1.61M Buy
520,650
+247,151
+90% +$766K ﹤0.01% 2959
2020
Q1
$604K Buy
273,499
+656
+0.2% +$1.45K ﹤0.01% 3219
2019
Q4
$832K Buy
272,843
+4,612
+2% +$14.1K ﹤0.01% 3335
2019
Q3
$824K Buy
268,231
+37,101
+16% +$114K ﹤0.01% 3296
2019
Q2
$462K Sell
231,130
-138,198
-37% -$276K ﹤0.01% 3493
2019
Q1
$1.59M Buy
369,328
+16,503
+5% +$71.1K ﹤0.01% 2979
2018
Q4
$1.12M Buy
352,825
+18,372
+5% +$58.4K ﹤0.01% 3062
2018
Q3
$1.76M Buy
334,453
+61,170
+22% +$321K ﹤0.01% 2956
2018
Q2
$1.46M Buy
273,283
+126,492
+86% +$677K ﹤0.01% 3021
2018
Q1
$733K Hold
146,791
﹤0.01% 3264
2017
Q4
$484K Hold
146,791
﹤0.01% 3369
2017
Q3
$550K Hold
146,791
﹤0.01% 3325
2017
Q2
$374K Sell
146,791
-5,812
-4% -$14.8K ﹤0.01% 3453
2017
Q1
$396K Buy
152,603
+6,664
+5% +$17.3K ﹤0.01% 3394
2016
Q4
$445K Buy
145,939
+528
+0.4% +$1.61K ﹤0.01% 3308
2016
Q3
$395K Buy
145,411
+14,079
+11% +$38.2K ﹤0.01% 3344
2016
Q2
$375K Sell
131,332
-37,302
-22% -$107K ﹤0.01% 3338
2016
Q1
$509 Buy
168,634
+2,254
+1% +$7 ﹤0.01% 3232
2015
Q4
$577K Buy
166,380
+264
+0.2% +$916 ﹤0.01% 3202
2015
Q3
$627K Buy
166,116
+15,627
+10% +$59K ﹤0.01% 3112
2015
Q2
$857K Buy
150,489
+13,143
+10% +$74.8K ﹤0.01% 2976
2015
Q1
$798K Sell
137,346
-33,024
-19% -$192K ﹤0.01% 2985
2014
Q4
$965K Sell
170,370
-804
-0.5% -$4.55K ﹤0.01% 2868
2014
Q3
$699K Buy
171,174
+6,848
+4% +$28K ﹤0.01% 2994
2014
Q2
$747K Buy
164,326
+39,432
+32% +$179K ﹤0.01% 2974
2014
Q1
$591K Buy
124,894
+34,435
+38% +$163K ﹤0.01% 3072
2013
Q4
$425K Sell
90,459
-26,357
-23% -$124K ﹤0.01% 3149
2013
Q3
$466K Buy
116,816
+4,928
+4% +$19.7K ﹤0.01% 2988
2013
Q2
$401K Buy
+111,888
New +$401K ﹤0.01% 2976